Showing results (91-100 of 160) with videos related to
Sort By:
Pageof 16
British Journal of Clinical Pharmacology|June 14, 2020
Drug-drug interaction between warfarin and statins: A Danish cohort studyAnna E Engell, Andreas L O Svendsen, Bent S Lind, et al.Diabetes Care|August 23, 2022
Dapagliflozin Improves the Urinary Proteomic Kidney-Risk Classifier CKD273 in Type 2 Diabetes with Albuminuria: A Randomized Clinical TrialViktor Rotbain Curovic, Mie Klessen Eickhoff, Teemu Rönkkö, et al.Diabetic Medicine : a Journal of the British Diabetic Association|November 12, 2020
Visit-to-visit variability of clinical risk markers in relation to long-term complications in type 1 diabetesViktor Rotbain Curovic, Simone Theilade, Signe Abitz Winther, et al.Cardiovascular Diabetology|July 13, 2017
Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, all-cause mortality and deterioration in kidney function in persons with type 2 diabetes and microalbuminuriaEmilie H Zobel, Bernt Johan von Scholten, Henrik Reinhard, et al.Cardiovascular Diabetology|August 28, 2013
24-hour central aortic systolic pressure and 24-hour central pulse pressure are related to diabetic complications in type 1 diabetes - a cross-sectional studySimone Theilade, Maria Lajer, Tine Willum Hansen, et al.Clinical Pharmacology and Therapeutics|October 22, 2024
Effect of Dapagliflozin on Measured vs. Panel-Estimated Glomerular Filtration RateEsben Iversen, Line Juel Nielsen, Viktor Rotbain Curovic, et al.Journal of Diabetes and Its Complications|May 1, 2020
Lipoprotein(a)and renal function decline, cardiovascular disease and mortality in type 2 diabetes and microalbuminuriaNiels Sondergaard Heinrich, Bernt Johan von Scholten, Henrik Reinhard, et al.Acta Diabetologica|August 15, 2018
Urinary tubular biomarkers as predictors of kidney function decline, cardiovascular events and mortality in microalbuminuric type 2 diabetic patientsViktor Rotbain Curovic, Tine W Hansen, Mie K Eickhoff, et al.Diabetes Care|July 10, 2009
Renal effects of aliskiren compared with and in combination with irbesartan in patients with type 2 diabetes, hypertension, and albuminuriaFrederik Persson, Peter Rossing, Henrik Reinhard, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 3, 2026
Effect of Semaglutide on Measured vs Estimated Glomerular Filtration RateRafal Yahya, Esben Iversen, Suvanjaa Sivalingam, et al.Pageof 16